交易 Vir Biotechnology 差价合约 — 实时图表

您好, user_no_name

立即交易

存入

退出
登录注册
ZH

语言

English English (Global)

English English (EU)

English English (UK)

English English (AU)

English English (ZA)

English English (St. Vincent)

Deutsch German

Español Spanish (Latam)

Español Spanish (Spain)

Français French

Dansk Danish

Italiano Italian

Nederlands Dutch

العربية Arabic

Svenka Swedish

Tiếng việt Vietnamese

Bahasa Melayu Malay

ภาษาไทย Thai

繁體中文 Traditional Chinese

简体中文 Simplified Chinese

Tagalog Tagalog

தமிழ் Tamil

हिन्दी Hindi

Português Portuguese

Bahasa Indonesia Indonesian

한국어 Korean

English English (BVI)
市场

产品

外汇

股票

商品

指数

加密貨幣CFD

ETFs

债券
交易

交易平台

Web 平台

应用

TradingView

MT4

MT5

Trading Central

交易工具

差价合约交易计算器

外汇交易保证金计算器

商品利润计算器

外汇交易利润计算器

经济事件日历

交易信息

差价合约交易

差价合约资产列表

交易条件

交易时段

到期日

近期交易休市日

每周到期展期

交易功能

市场深度
学习

学习交易

术语表

教育中心

交易基础知识

视频库

新闻与分析

新闻

社区
推广

marketsClub

欢迎奖金

积分奖

推荐促销
加盟

加盟

IB
关于

Markets.com 简介

为何选择 markets.com

全球服务

集团简介

奖项和媒体

帮助与支持

常见问题解答

帮助中心

联系客服

投诉

数据与安全

安全上网

Cookie 披露声明

法律资源包

合法交易条例

法规

搜索

语言

登录注册

VirBiotechnology 实时图表

5m 15m 30m 1h 4h 1d 1w

金融票据基础知识

历史数据

日期	关闭	更改	更改(%)：	开盘价	高	低

最新新闻

Frances Wang 2025 Apr 23, 16:00

Hang Seng Index Gains on Strong China GDP amid Trump Tariffs Uncertainty

Indices

Frances Wang 2025 Apr 23, 16:00

Forex news today: GBP/USD gains, USD/JPY declines, EUR/USD strengthens

Forex

Frances Wang 2025 Apr 23, 16:00

Trending stocks to watch: AMD, GOOG, NVDA, AMZN, MSFT

Stocks

Tommy Yap 2025 Apr 23, 16:00

Morning Note: Tariff Deadlock Grips US-China Trade; Alphabet's Report Looms; BOJ Dilemma

Morning Note Tech

Frances Wang 2025 Apr 22, 16:00

Commodity market today: Crude Oil Fluctuates as OPEC+ Modifies Production Goals

Commodities

Tommy Yap 2025 Apr 22, 16:00

Morning Note: Trump Calms Fed Fears; Tesla Disappoints; UK Trade Talks Begin

Morning Note Tech

Frances Wang 2025 Apr 21, 16:00

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Stocks Indices

Tommy Yap 2025 Apr 21, 16:00

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Morning Note Stocks Commodities

概览
关键统计数据
见解
关于

信息

点差

0.07

点差(%)

1.1218 %

杠杆

1:10

隔夜利息（买入）

-0.0597 %

隔夜利息（卖出）

-0.0292 %

币种

USD

交易时间

市场关闭

星期五

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

分析和统计

开盘价

---

昨收

---

52 周高点/低点

--- – ---

市值

824242048

在外流通股份

138064000

财报日（下一）

0000-00-00

股息收益率

除息日

远期年度股息率

远期年股息率

每股收益

-3.94

详细了解此金融票据

Vir Biotechnology Vir Biotechnology Inc

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.